Literature DB >> 30355192

Predictors of Unexpected Early Reocclusion After Successful Mechanical Thrombectomy in Acute Ischemic Stroke Patients.

Pascal J Mosimann1, Johannes Kaesmacher1, Dominic Gautschi1, Sebastian Bellwald1,2, Leonidas Panos2, Eike Piechowiak1, Tomas Dobrocky1, Felix Zibold1, Pasquale Mordasini1, Marwan El-Koussy1, Roland Wiest1, David Bervini3, Franca Wagner1, Marcel Arnold2, Simon Jung2, Aikaterini Galimanis2, Jan Gralla1, Urs Fischer2.   

Abstract

Background and Purpose- Sustained successful reperfusion is an important prognostic factor for good clinical outcome in acute ischemic stroke. We aimed to identify the prevalence, clinical impact, and predictors of early reocclusion after initially successful thrombectomies within a prospective cohort. Methods- A total of 711 stroke patients with successful reperfusion (modified Thrombolysis in Cerebral Infarction, 2b/3) followed with magnetic resonance or computed tomographic angiography at 24 to 48 hours were included. Multivariable logistic regression analysis was used to evaluate associated factors and clinical impact. Results are displayed as adjusted odds ratio (aOR) and 95% CI. Improvement in accuracy of additional imaging findings on angiography control runs after the intervention was evaluated by area under the curve. Results- Early reocclusion was observed in 16 of 711 successfully reperfused patients (2.3%; 95% CI, 1.1-3.3; median delay: 20 hours). Suggestive predictors were higher platelets on admission (aOR, 1.01; 95% CI, 1.01-1.02), prestroke functional dependence (aOR, 7.12; 95% CI, 1.49-34.03), and stroke of undetermined or other specified pathogenesis in the TOAST classification (aOR, 7.19; 95% CI, 1.10-47.05 and aOR, 36.50; 95% CI, 4.47-298.11, respectively). When implementing residual embolic fragments or stenosis at the thrombectomy site into the logistic regression model, discrimination between patients with and without reocclusion improved significantly (area under the curve, 0.955 versus 0.854; P=0.023). Early reocclusion was an independent predictor of unfavorable outcome at 90 days (aOR for modified Rankin Scale ≤2, 0.13; 95% CI, 0.03-0.57). Conclusions- Early reocclusion within 48 hours after successful mechanical thrombectomy is rare but associated with poor outcome. Patients with high platelets on admission and residual embolic fragments or stenosis at the thrombectomy site are at high risk for reocclusion, which may be prevented or corrected after carefully re-evaluating the last angiographic run.

Entities:  

Keywords:  angiography; ischemia; reperfusion; stroke; thrombectomy

Mesh:

Year:  2018        PMID: 30355192     DOI: 10.1161/STROKEAHA.118.021685

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  16 in total

1.  Rescue stenting versus medical care alone in refractory large vessel occlusions: a systematic review and meta-analysis.

Authors:  Kévin Premat; Agnes Dechartres; Stéphanie Lenck; Eimad Shotar; Raphaël Le Bouc; Vincent Degos; Nader Sourour; Sonia Alamowitch; Yves Samson; Frédéric Clarençon
Journal:  Neuroradiology       Date:  2020-01-11       Impact factor: 2.804

2.  Safety and Efficacy of Intra-arterial Urokinase After Failed, Unsuccessful, or Incomplete Mechanical Thrombectomy in Anterior Circulation Large-Vessel Occlusion Stroke.

Authors:  Johannes Kaesmacher; Sebastian Bellwald; Tomas Dobrocky; Thomas R Meinel; Eike I Piechowiak; Martina Goeldlin; Christoph C Kurmann; Mirjam R Heldner; Simon Jung; Pasquale Mordasini; Marcel Arnold; Pascal J Mosimann; Gerhard Schroth; Heinrich P Mattle; Jan Gralla; Urs Fischer
Journal:  JAMA Neurol       Date:  2020-03-01       Impact factor: 18.302

3.  Reperfusion therapy in a patient with early recurrence of ischemic stroke.

Authors:  Marina Bralic; Matija Sosic; Slavica Kovacic; Vladimira Vuletic
Journal:  Neurol Sci       Date:  2021-09-03       Impact factor: 3.307

4.  Endovascular treatment of acute ischemic stroke in patients with recurrent intracranial large vessel occlusion.

Authors:  Andrej Klepanec; Jan Harsany; Jozef Haring; Miroslav Mako; Matus Hoferica; Matej Rusina; Juraj Cisar; Georgi Krastev
Journal:  Interv Neuroradiol       Date:  2020-03-17       Impact factor: 1.610

5.  Etiology of recurrent large vessel occlusions treated with repeated thrombectomy.

Authors:  B Ikenberg; J Rösler; C L Seifert; S Wunderlich; J Kaesmacher; C Zimmer; T Boeckh-Behrens; B Friedrich; C Maegerlein
Journal:  Interv Neuroradiol       Date:  2019-12-10       Impact factor: 1.610

Review 6.  Dual-energy computed tomography in acute ischemic stroke: state-of-the-art.

Authors:  Stephanie Mangesius; Tanja Janjic; Ruth Steiger; Lukas Haider; Rafael Rehwald; Michael Knoflach; Gerlig Widmann; Elke Gizewski; Astrid Grams
Journal:  Eur Radiol       Date:  2020-12-14       Impact factor: 5.315

7.  Perfusion image guided mechanical thrombectomy combined with tirofiban successfully revascularize systemic lupus erythematosus related acute large vessel occlusion: A case report.

Authors:  Han Wang; Haitao Hu; Jing Xu; Cong Qian
Journal:  Medicine (Baltimore)       Date:  2021-05-07       Impact factor: 1.889

8.  Infarct Growth despite Successful Endovascular Reperfusion in Acute Ischemic Stroke: A Meta-analysis.

Authors:  F Bala; J Ospel; B Mulpur; B J Kim; J Yoo; B K Menon; M Goyal; C Federau; S-I Sohn; M S Hussain; M A Almekhlafi
Journal:  AJNR Am J Neuroradiol       Date:  2021-06-03       Impact factor: 4.966

9.  Antiplatelet therapy within 24 hours of tPA: lessons learned from patients requiring combined thrombectomy and stenting for acute ischemic stroke.

Authors:  Michael G Brandel; Yasmeen Elsawaf; Robert C Rennert; Jeffrey A Steinberg; David R Santiago-Dieppa; Arvin R Wali; Scott E Olson; J Scott Pannell; Alexander A Khalessi
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2020-03-31

10.  Prognosis and risk factors for reocclusion after mechanical thrombectomy.

Authors:  Weili Li; Jiayue Ding; Xueqin Sui; Zhifeng Qi; Longfei Wu; Chenghe Sun; Kangxiang Ji; Qingfeng Ma; Xunming Ji; Ke Jian Liu
Journal:  Ann Clin Transl Neurol       Date:  2020-03-10       Impact factor: 4.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.